Firequark software

SitePilot.
Portable site planning and review.

Plan and inspect website work with explicit provider-unavailable states instead of pretending a live integration exists.

SitePilot status

  • Current Track A software is technically complete and deployed as a controlled beta on the shared-host profile.
  • The shared-host beta is explicitly non-production-grade; external reads and writes remain off by default.
  • Synthetic and fictional records demonstrate software behavior, not customer results or market validation.

Portable site planning and review

Plan and inspect website work with explicit provider-unavailable states instead of pretending a live integration exists.

SitePilot is part of Firequark Growth OS rather than a disconnected marketing service. Its workflows preserve review, tenant scope and evidence boundaries.

Capabilities

Inside SitePilot.

01

Planning

Portable site plans and manual snapshots provide useful work without a required live provider.

02

State

Unavailable providers are shown as unavailable instead of silently mocked.

03

Action

Regression work is created only from deterministic differences and remains reviewed.

Deployment profiles

One product contract,
two operating profiles.

ProfileUseCurrent boundary
DreamHost shared MVPInternal use and authorized controlled betaStatic app, PHP API, SQLite, bounded cron; non-production-grade
Production profileFuture higher-scale operationNext server, API, workers, PostgreSQL RLS, Redis and private objects; not publicly launched

What remains external

Technical completion
is not market proof.

Real-user validation

Fixtures cannot satisfy paid activation, retention or customer-outcome gates.

Provider launch

Live messaging, publishing, ads, billing and other consequential providers require separate credentials and approval.

Production operation

Monitoring ownership, support, legal review, backups and production infrastructure remain launch decisions.

Ignition

Evaluate SitePilot with a guided proof-of-value.

The fixed-scope starting product is a 30-day controlled-beta evaluation with explicit boundaries and no invented result claims.